The L1 Adhesion Molecule is a Cellular Ligand for VLA-5
Overview
Authors
Affiliations
The L1 adhesion molecule is a member of the immunoglobulin superfamily shared by neural and immune cells. In the nervous system L1 can mediate cell binding by a homophilic mechanism. To analyze its function on leukocytes we studied whether L1 could interact with integrins. Here we demonstrate that VLA-5, an RGD-specific fibronectin receptor on a wide variety of cell types, can bind to murine L1. Mouse ESb-MP cells expressing VLA-5 and L1 could be induced to aggregate in the presence of specific mAbs to CD24 (heat-stable antigen), a highly and heterogeneously glycosylated glycophosphatidylinositol-linked differentiation antigen of hematopoietic and neural cells. The aggregation was blocked by both mAbs to L1 and VLA-5, respectively. Aggregation was blocked also by a synthetic RGD-containing peptide derived from the Ig-domain VI of the L1 protein. ESb-MP subclones with low L1 expression could not aggregate. In heterotypic binding assays mouse bone marrow cells could adhere in an L1-dependent fashion to platelets that expressed VLA-5. Also purified L1 coated to polystyrene beads could bind to platelets. The binding of L1-beads was again inhibited by mAbs to L1 and VLA-5, by soluble L1 and the L1-RGD peptide in a dose-dependent manner. Thymocytes or human Nalm-6 tumor cells expressing VLA-5 could adhere to affinity-purified L1 and to the L1-derived RGD-containing peptide coated to glass slides. The adhesion was strongly enhanced in the presence of Mn(2+)-ions and blocked by mAbs to VLA-5. We also demonstrate a direct L1-VLA-5 protein interaction. Our results suggest a novel binding pathway, in which the VLA-5 integrin binds to L1 on adjacent cells. Given its rapid downregulation on lymphocytes after induction of cell proliferation, L1 may be important in integrin-mediated and activation-regulated cell-cell interactions.
Tramontano C, Martins J, De Stefano L, Kemell M, Correia A, Terracciano M Adv Healthc Mater. 2022; 12(6):e2202672.
PMID: 36459471 PMC: 11468342. DOI: 10.1002/adhm.202202672.
Emamnejad R, Dass M, Mahlis M, Bozkurt S, Ye S, Pagnin M Front Pharmacol. 2022; 13:934971.
PMID: 36133808 PMC: 9483185. DOI: 10.3389/fphar.2022.934971.
Case Report: Two Novel Mutations in Two Unrelated Chinese Families With X-Linked Hydrocephalus.
Zhou H, Yu Q, Li Y, Fu F, Li R, Chen G Front Genet. 2022; 13:810853.
PMID: 35571029 PMC: 9099044. DOI: 10.3389/fgene.2022.810853.
Hu J, Lin S, Schachner M Cell Death Dis. 2022; 13(1):48.
PMID: 35013124 PMC: 8748658. DOI: 10.1038/s41419-021-04348-6.
Impact of Nischarin on EMT regulators in breast cancer cell lines.
Cai Y, Ma B, Wang M, Chen J, Zhao F, Zhou J Oncol Lett. 2020; 20(6):291.
PMID: 33101485 PMC: 7576990. DOI: 10.3892/ol.2020.12154.